All cases were presented in a multidisciplinary liver tumor
board, including hepatologists, hepatic surgeons, radiation oncologists
and radiologists. All patients signed an informed consent to be
treated. This study was approved by our institutional research
ethics committee and by the French computer watchdog (CNIL).